相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Kindlin3-Dependent CD11b/CD18-Integrin Activation Is Required for Potentiation of Neutrophil Cytotoxicity by CD47-SIRPα Checkpoint Disruption
Panagiota Bouti et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Specific and Sensitive Detection of Neuroblastoma mRNA Markers by Multiplex RT-qPCR
Lieke M. J. van Zogchel et al.
CANCERS (2021)
Flow Cytometric Methods for the Detection of Intracellular Signaling Proteins and Transcription Factors Reveal Heterogeneity in Differentiating Human B Cell Subsets
Casper Marsman et al.
CELLS (2020)
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel
Esther M. van Wezel et al.
JCO PRECISION ONCOLOGY (2019)
Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis
Hanke L. Matlung et al.
CELL REPORTS (2018)
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
Ruth Ladenstein et al.
LANCET ONCOLOGY (2018)
High-Risk Neuroblastoma Treatment Review
Valeria Smith et al.
CHILDREN-BASEL (2018)
Patient-derived xenografts as preclinical neuroblastoma models
Noemie Braekeveldt et al.
CELL AND TISSUE RESEARCH (2018)
Overview and recent advances in the treatment of neuroblastoma
Sarah B. Whittle et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Neuroblastoma is composed of two super-enhancer-associated differentiation states
Tim van Groningen et al.
NATURE GENETICS (2017)
Dinutuximab for maintenance therapy in pediatric neuroblastoma
Lauren McGinty et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2017)
Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap
Evgeniy B. Eruslanov et al.
TRENDS IN CANCER (2017)
Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells
Ramraj Velmurugan et al.
MOLECULAR CANCER THERAPEUTICS (2016)
G-CSF Is a Cancer Stem Cell-Specific Growth Factor-Letter
John M. Maris et al.
CANCER RESEARCH (2015)
G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation
Saurabh Agarwal et al.
CANCER RESEARCH (2015)
Mouse and human FcR effector functions
Pierre Bruhns et al.
IMMUNOLOGICAL REVIEWS (2015)
Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours
Laurel T. Bate-Eya et al.
EUROPEAN JOURNAL OF CANCER (2014)
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy
Mahiuddin Ahmed et al.
FEBS LETTERS (2014)
G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic
Danielle M. Hsu et al.
CANCER RESEARCH (2013)
Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
Julie R. Park et al.
PEDIATRIC BLOOD & CANCER (2013)
Activation of Peripheral-Blood Granulocytes Is Strongly Correlated With Patient Outcome After Immunotherapy With Anti-GD2 Monoclonal Antibody and Granulocyte-Macrophage Colony-Stimulating Factor
Irene Y. Cheung et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study
Ruth Ladenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Detecting Minimal Residual Disease in Neuroblastoma: The Superiority of a Panel of Real-Time Quantitative PCR Markers
Janine Stutterheim et al.
CLINICAL CHEMISTRY (2009)
Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report From the Children's Oncology Group
Andrew L. Gilman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Pegfilgrastim for Prevention of Chemotherapy-Associated Neutropenia in Pediatric Patients With Solid Tumors
Scott C. Borinstein et al.
PEDIATRIC BLOOD & CANCER (2009)
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Matthias Peipp et al.
BLOOD (2008)
Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis
Jing Yang et al.
DEVELOPMENTAL CELL (2008)
PHOX2B Is a Novel and Specific Marker for Minimal Residual Disease Testing in Neuroblastoma
Janine Stutterheim et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells: implications for disease-free survival of high-risk patients
Andre N. Gay et al.
JOURNAL OF PEDIATRIC SURGERY (2008)
Once-per-cycle pegfilgrastim versus daily filgrastim in pediatric patients with Ewing sarcoma
G Wendelin et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis
A Schneider et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
MD Green et al.
ANNALS OF ONCOLOGY (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
分享论文
